• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MATCAP1优先结合扩展的微管蛋白构象以生成去酪氨酸化和ΔC2α-微管蛋白。

MATCAP1 preferentially binds an expanded tubulin conformation to generate detyrosinated and ΔC2 α-tubulin.

作者信息

Yue Yang, Hotta Takashi, Ohi Ryoma, Verhey Kristen J

出版信息

bioRxiv. 2025 Aug 18:2025.08.14.670257. doi: 10.1101/2025.08.14.670257.

DOI:10.1101/2025.08.14.670257
PMID:40894690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393276/
Abstract

Microtubules are cytoskeletal filaments with critical roles in cell division, cell motility, intracellular trafficking, and cilium function. In cells, subsets of microtubules are selectively marked by posttranslational modifications (PTMs), which control the ability of microtubule-associated proteins (MAPs) and molecular motors to engage microtubules. Detyrosination (ΔY) and ΔC2 are PTMs of α-tubulin, wherein one or two residues, respectively, are enzymatically removed from the C-terminus of the protein. How specific patterns of PTMs are generated in cells is not understood. Here, we use in vitro reconstitution assays to investigate the microtubule binding behavior of metallopeptidase MATCAP1 and the mechanism by which it generates ΔY and ΔC2 modifications of α-tubulin. We demonstrate that MATCAP1 preferentially binds to microtubules composed of tubulin subunits in an expanded conformation, which can be induced by preventing β-tubulin GTP hydrolysis, Taxol treatment, or kinesin-1 stepping. MATCAP1 binds to expanded microtubule lattices with long dwell time and sequentially removes the terminal tyrosine residue to generate ΔY-microtubules and the penultimate glutamate residue to generate ΔC2-microtubules. Thus, the lattice conformation of microtubules is a key factor that gates the binding and activity of MATCAP1.

摘要

微管是细胞骨架丝,在细胞分裂、细胞运动、细胞内运输和纤毛功能中起关键作用。在细胞中,微管的亚群通过翻译后修饰(PTM)被选择性标记,这些修饰控制微管相关蛋白(MAP)和分子马达与微管结合的能力。去酪氨酸化(ΔY)和ΔC2是α-微管蛋白的PTM,其中分别有一个或两个残基从蛋白质的C末端被酶促去除。细胞中如何产生特定的PTM模式尚不清楚。在这里,我们使用体外重组实验来研究金属肽酶MATCAP1的微管结合行为及其产生α-微管蛋白的ΔY和ΔC2修饰的机制。我们证明,MATCAP1优先结合由处于扩展构象的微管蛋白亚基组成的微管,这种构象可以通过阻止β-微管蛋白GTP水解、紫杉醇处理或驱动蛋白-1步进诱导产生。MATCAP1以较长的停留时间结合到扩展的微管晶格上,并依次去除末端酪氨酸残基以产生ΔY-微管,去除倒数第二个谷氨酸残基以产生ΔC2-微管。因此,微管的晶格构象是控制MATCAP1结合和活性的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/aa95567392d3/nihpp-2025.08.14.670257v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/32240f3ee293/nihpp-2025.08.14.670257v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/8cd729ab1eca/nihpp-2025.08.14.670257v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/081ccdf3bb75/nihpp-2025.08.14.670257v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/d5c373c38402/nihpp-2025.08.14.670257v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/484205eb26cd/nihpp-2025.08.14.670257v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/aa95567392d3/nihpp-2025.08.14.670257v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/32240f3ee293/nihpp-2025.08.14.670257v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/8cd729ab1eca/nihpp-2025.08.14.670257v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/081ccdf3bb75/nihpp-2025.08.14.670257v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/d5c373c38402/nihpp-2025.08.14.670257v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/484205eb26cd/nihpp-2025.08.14.670257v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b435/12393276/aa95567392d3/nihpp-2025.08.14.670257v1-f0006.jpg

相似文献

1
MATCAP1 preferentially binds an expanded tubulin conformation to generate detyrosinated and ΔC2 α-tubulin.MATCAP1优先结合扩展的微管蛋白构象以生成去酪氨酸化和ΔC2α-微管蛋白。
bioRxiv. 2025 Aug 18:2025.08.14.670257. doi: 10.1101/2025.08.14.670257.
2
Abl2 repairs microtubules and phase separates with tubulin to promote microtubule nucleation.Abl2 修复微管并与微管蛋白相分离以促进微管成核。
Curr Biol. 2023 Nov 6;33(21):4582-4598.e10. doi: 10.1016/j.cub.2023.09.018. Epub 2023 Oct 18.
3
Microtubule detyrosination by VASH1/SVBP is regulated by the conformational state of tubulin in the lattice.VASH1/SVBP 通过微管去酪氨酸化来调节晶格中微管蛋白的构象状态。
Curr Biol. 2023 Oct 9;33(19):4111-4123.e7. doi: 10.1016/j.cub.2023.07.062. Epub 2023 Sep 15.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Systematic Identification of Microtubule Posttranslational Modification "Readers" by Quantitative Proteomics.通过定量蛋白质组学系统鉴定微管翻译后修饰“读码器”。
Methods Mol Biol. 2025;2872:189-203. doi: 10.1007/978-1-0716-4224-5_13.
6
The Binding of Protein l-Isoaspartyl Methyltransferase (PIMT) to Tubulin and Disruption of Microtubule Assembly Leading to Tumor Regression.蛋白质l-异天冬氨酰甲基转移酶(PIMT)与微管蛋白的结合以及微管组装的破坏导致肿瘤消退。
Biochemistry. 2025 Jul 1;64(13):2765-2777. doi: 10.1021/acs.biochem.5c00087. Epub 2025 Jun 20.
7
Competition for microtubule lattice spacing between a microtubule expander and compactor.微管扩张剂和压缩剂之间对微管晶格间距的竞争。
Curr Biol. 2025 Aug 27. doi: 10.1016/j.cub.2025.07.080.
8
Purification, Fluorescent Labeling, and Detyrosination of Mammalian Cell Tubulin for Biochemical Assays.用于生化分析的哺乳动物细胞微管蛋白的纯化、荧光标记及去酪氨酸化
Cytoskeleton (Hoboken). 2025 Jul 12. doi: 10.1002/cm.70005.
9
The types and numbers of kinesins and dyneins transporting endocytic cargoes modulate their motility and response to tau.运输内吞货物的驱动蛋白和动力蛋白的类型和数量调节了它们的运动性和对 tau 的反应。
J Biol Chem. 2024 Jun;300(6):107323. doi: 10.1016/j.jbc.2024.107323. Epub 2024 Apr 25.
10
Modeling Study of Effects of Tubulin Carboxy-Terminal Tails on Dynamics of Kinesin and Dynein Motors.微管蛋白羧基末端尾巴对驱动蛋白和动力蛋白运动动力学影响的建模研究
Protein J. 2025 Apr 26. doi: 10.1007/s10930-025-10267-8.

本文引用的文献

1
Competition for microtubule lattice spacing between a microtubule expander and compactor.微管扩张剂和压缩剂之间对微管晶格间距的竞争。
Curr Biol. 2025 Aug 27. doi: 10.1016/j.cub.2025.07.080.
2
Purification, Fluorescent Labeling, and Detyrosination of Mammalian Cell Tubulin for Biochemical Assays.用于生化分析的哺乳动物细胞微管蛋白的纯化、荧光标记及去酪氨酸化
Cytoskeleton (Hoboken). 2025 Jul 12. doi: 10.1002/cm.70005.
3
Structural switching of tubulin in the microtubule lattice.微管晶格中微管蛋白的结构转换。
Biochem Soc Trans. 2025 Feb 5;53(1):BST20240360. doi: 10.1042/BST20240360.
4
Tubulin tyrosination/detyrosination regulate the affinity and sorting of intraflagellar transport trains on axonemal microtubule doublets.微管蛋白酪氨酸化/去酪氨酸化调节轴丝微管双联体上鞭毛内运输列车的亲和力和分选。
Nat Commun. 2025 Jan 26;16(1):1055. doi: 10.1038/s41467-025-56098-0.
5
Decoding microtubule detyrosination: enzyme families, structures, and functional implications.解析微管去酪氨酸化:酶家族、结构和功能意义。
FEBS Lett. 2024 Jun;598(12):1453-1464. doi: 10.1002/1873-3468.14940. Epub 2024 May 29.
6
Microtubule-associated protein MAP7 promotes tubulin posttranslational modifications and cargo transport to enable osmotic adaptation.微管相关蛋白 MAP7 促进微管蛋白翻译后修饰和货物运输,以实现渗透适应。
Dev Cell. 2024 Jun 17;59(12):1553-1570.e7. doi: 10.1016/j.devcel.2024.03.022. Epub 2024 Apr 3.
7
Efficient axonal transport of endolysosomes relies on the balanced ratio of microtubule tyrosination and detyrosination.内溶酶体的有效轴突运输依赖于微管酪氨酸化和去酪氨酸化的平衡比例。
J Cell Sci. 2024 Apr 15;137(8). doi: 10.1242/jcs.261737. Epub 2024 Apr 30.
8
Microtubule detyrosination by VASH1/SVBP is regulated by the conformational state of tubulin in the lattice.VASH1/SVBP 通过微管去酪氨酸化来调节晶格中微管蛋白的构象状态。
Curr Biol. 2023 Oct 9;33(19):4111-4123.e7. doi: 10.1016/j.cub.2023.07.062. Epub 2023 Sep 15.
9
A family of carboxypeptidases catalyzing α- and β-tubulin tail processing and deglutamylation.一种羧肽酶家族,可催化 α-和 β-微管蛋白尾部加工和脱谷氨酸化。
Sci Adv. 2023 Sep 15;9(37):eadi7838. doi: 10.1126/sciadv.adi7838. Epub 2023 Sep 13.
10
Microtubule detyrosination drives symmetry breaking to polarize cells for directed cell migration.微管去酪氨酸化驱动对称破缺以使细胞极化,从而进行定向细胞迁移。
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2300322120. doi: 10.1073/pnas.2300322120. Epub 2023 May 22.